About The Study: The results of this study suggest that receipt of a fourth dose of the Pfizer-BioNTech vaccine conferred high protection against COVID-19 hospitalizations and deaths among long-term care facility residents in Israel during a substantial Omicron variant surge but protection was modest against infection.
Authors: Khitam Muhsen, Ph.D., of Tel Aviv University in Tel Aviv, Israel, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.2658?guestAccessKey=5a1cc8de-6664-4251-9169-f771b4051360&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062322
JAMA Internal Medicine